Serum zinc deficiency and progression of cardiovascular- kidney-metabolic syndrome.
文献摘要
Introduction Cardiovascular-kidney-metabolic (CKM) syndrome represents an interconnected disease continuum linking metabolic dysfunction, chronic kidney disease (CKD), and cardiovascular disease. Serum zinc deficiency (SZD) has been associated with adverse cardiovascular and renal outcomes; however, its association with CKM progression remains unclear. Methods This retrospective cohort study was conducted using the TriNetX. Adults with CKM stage 1 or 2 were enrolled in the study. SZD was defined as a serum zinc concentration Results Among 148,490 matching individuals, SZD was associated with a significantly increased risk of operational progression to CKM stage 3-4 compared with normal zinc status (HR, 1.36; 95% CI, 1.30-1.41; P P Conclusion Among patients with CKM stage 1-2, SZD was associated with a significantly increased risk of operational progression to CKM stage 3-4 and a broad spectrum of adverse cardiovascular, renal, and mortality outcomes. These findings suggest that SZD may represent an important marker of adverse CKM health and may help identify individuals at increased risk for CKM progression.